Levels of myomiRs and EVs in the sera of DMD patients andmdxmice. miRNAs and creatine kinase in the serum of GW4869-treatedmdxmice were significantly downregulated compared with those of controls. The tibialis anterior muscles from the GW4869-treatedmdxmice showed a robust decrease in Evans blue dye uptake. Collectively, these results indicate that EVs and myomiRs might safeguard the skeletal muscle ofmdxmice from degeneration. == Intro == Duchenne muscular dystrophy (DMD; OMIM #310200) is an X-linked recessive, severe and progressive muscle disease with a prevalence of 1 in 3, 500 live male births, and is caused by mutations in thedystrophingene [1, 2]. This disorder is usually KX2-391 2HCl first recognized by muscular weakness from two to five years of age. Consequently, patients drop their ability Mouse monoclonal to IGF2BP3 to ambulate before 12 years of age, and eventually experience failure of respiratory and cardiac functions owing to degeneration of the diaphragm and cardiac muscles [3]. Serum creatine kinase (CK), which reflects the level of muscle damage, is commonly used as a diagnostic marker intended for DMD. However , false-positive or false-negative results are commonly noticed, because CK release is increased by various factors, such as vigorous exercise [4], and is decreased by disease progression with age group following the lack of muscle tissue [5], rendering quantitative diagnosis and prognostic applications of CK difficult. Thus, reliable biomarkers of DMD have been anticipated. miRNAs are non-coding single stranded RNAs containing approximately 21 to 24 nucleotides, which regulate gene expression by base-pairing of their nucleotides 2 to 8 with the 5- or 3-untranslated regions of target mRNAs, primarily in the cytoplasm [68]. As the activities of approximately 50% of all coding genes in mammals are predicted to be regulated by miRNAs, the dysregulation of their expressions is associated with the pathophysiological conditions of many disorders. Some miRNAs are encapsulated into microvesicles, exosomes, or apoptotic bodies, whereas other miRNAs form complexes with RNA-binding proteins [916]. They can be internalized by recipient cells via extracellular vesicles (EVs), leading to the intercellular communication [1318]. Despite the large levels of RNase activity within the circulating blood, because miRNAs are protected from RNase by their relationship with RNA-binding protein(s) or their inclusion within EVs, remarkably stable miRNAs were shown to be secreted into the extracellular space in non-vesicular or vesicular-encapsulated forms [1921]. Several groups, including our own, previously reported that three myomiRs, namely, miR-1, miR-133a, and miR-206, were increased in the KX2-391 2HCl sera of creature models of muscular dystrophy as well as in patients [2224]. This upregulation in myomiR levels is not limited to DMD patients, because increased levels of miR-1 were found in the sera of Becker muscular dystrophy (BMD), facioscapulohumeral muscular dystrophy, and limb-girdle muscular dystrophy patients, and increased levels of miR-133a and miR-206 were found in BMD patients [25]. In addition , myomiR levels were shown to be inversely correlated with disease severity in DMD patients aged three to six years [22]. The increased levels of myomiRs in the sera ofmdxmice have been demonstrated to be increased to near wild-type levels by restoration from the dystrophin protein using exon-skipping therapies [26]. On the other hand, in the muscle ofmdxmice, miR-1 and miR-133a levels have been shown to be downregulated, whereas miR-206 levels are upregulated [26, 27]. The expression of miR-1 and miR-133a in KX2-391 2HCl skeletal muscle can be restored by rescue of the dystrophin protein using exon-skipping techniques [27, 28]. These myomiRs possess multiple roles in muscle development and regeneration, such as the regulation of genes involved in myogenesis, proliferation, and muscle fiber-type conversion [29, 30]. Thus, miRNAs have been identified not only because noninvasive biomarkers of DMD, but also KX2-391 2HCl as therapeutic targets for a lot of disorders. However , the potential involvement of these muscle-abundant miRNAs in the pathogenesis of DMD remains unclear. Elucidating the pathways regulating the release of myomiRs will be useful towards gaining a better understanding of DMD pathogenesis and new targets intended for therapies. In fact , the release of miRNAs into intracellular and extracellular spaces was shown to be controlled by the neutral sphingomyelinase 2/ sphingomyelin phosphodiesterase 3 (nSMase2/SMPD3)-regulated secretory machinery of exosomes, which are membrane microvesicles about 30100 nm in size generated from multivesicular bodies (MVBs) of the terminal endosomal pathway via the biogenesis of ceramide from sphingomyelin [3135]. However , the mechanisms regulating the functions of myomiRs transported via EVs, including exosomes or larger vesicles, in the pathogenesis.